Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Covington
Julphar
Healthtrust
Chubb
UBS
Merck
AstraZeneca
US Army
Accenture

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020021

« Back to Dashboard

NDA 020021 describes SUDAFED 24 HOUR, which is a drug marketed by J And J Consumer Inc and is included in one NDA. It is available from one supplier. Additional details are available on the SUDAFED 24 HOUR profile page.

The generic ingredient in SUDAFED 24 HOUR is pseudoephedrine hydrochloride. There are forty-nine drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the pseudoephedrine hydrochloride profile page.
Summary for 020021
Tradename:SUDAFED 24 HOUR
Applicant:J And J Consumer Inc
Ingredient:pseudoephedrine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020021
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUDAFED 24 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020021 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-669 N 50580-669-10

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength240MG
Approval Date:Dec 15, 1992TE:RLD:Yes

Expired US Patents for NDA 020021

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc SUDAFED 24 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020021-002 Dec 15, 1992 ➤ Sign Up ➤ Sign Up
J And J Consumer Inc SUDAFED 24 HOUR pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020021-002 Dec 15, 1992 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Healthtrust
Accenture
McKinsey
Fish and Richardson
US Army
Moodys
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot